Secondary Pseudohypoaldosteronism in Infants with UTI
Secondary pseudohypoaldosteronism (S-PHA) is a life-threatening but transient condition that occurs in approximately 90% of cases when infants under 6 months with urinary tract infections (UTI) and/or congenital urinary tract malformations develop renal tubular resistance to aldosterone, resulting in severe hyponatremia, hyperkalemia, and metabolic acidosis.
Mechanism of UTI-Induced Pseudohypoaldosteronism
The pathophysiology involves renal tubular resistance to aldosterone triggered by multiple factors 1, 2:
- Increased intrarenal pressure from infection and/or obstruction damages tubular function
- Inflammatory mediators from UTI directly impair aldosterone receptor sensitivity in the distal tubules
- Tubular immaturity in infants under 6 months makes them particularly vulnerable to aldosterone resistance
- The combination creates a functional blockade where despite markedly elevated plasma renin and aldosterone levels, the kidneys cannot retain sodium or excrete potassium
This differs fundamentally from primary pseudohypoaldosteronism (genetic defect) or congenital adrenal hyperplasia (inadequate aldosterone production) - in S-PHA, the hormones are present in excess but the tubules cannot respond to them.
Prevalence and Risk Factors in Infants
S-PHA is uncommon but clinically significant when it occurs 1, 3:
Age Distribution
- 92.2% of cases occur in infants younger than 6 months 1
- Peak incidence in the first 3 months of life
- Rare after 1 year of age
Gender and Associated Conditions
- 81.9% occur in males 1, likely due to higher rates of obstructive uropathy (posterior urethral valves)
- 90.5% have concurrent UTI 1
- 50.9% have bilateral urinary tract malformations or solitary kidney 1
Specific Risk Profile
The highest-risk infant is:
- Male, under 3 months old
- Has obstructive uropathy (posterior urethral valves, vesicoureteral reflux grades III-V, hydronephrosis)
- Presents with acute pyelonephritis
- May have bilateral involvement or solitary kidney
Without UTI, S-PHA occurs almost exclusively with bilateral malformations 1, suggesting infection is the primary trigger in unilateral disease.
Clinical Recognition
Presentation
Infants present with nonspecific symptoms that mimic other serious conditions 4, 5:
- Failure to thrive, poor weight gain
- Vomiting and dehydration
- Lethargy or irritability
- May progress to shock and respiratory distress requiring intensive care
Laboratory Hallmarks
- Severe hyponatremia (often <120 mmol/L)
- Hyperkalemia (typically >6.0 mmol/L)
- Metabolic acidosis with normal anion gap
- Markedly elevated plasma renin activity and aldosterone (distinguishes from adrenal insufficiency)
- Positive urine culture (usually E. coli or Klebsiella)
Critical Pitfall
The presentation mimics salt-losing congenital adrenal hyperplasia, which is the most important differential diagnosis 2, 5. Key distinguishing features:
- S-PHA: High aldosterone and renin (resistance)
- CAH: Low/normal aldosterone, high 17-hydroxyprogesterone (deficiency)
- S-PHA: UTI and/or uropathy on imaging
- CAH: Normal urinary tract, ambiguous genitalia in females
Management Approach
Treatment is primarily supportive, targeting the underlying infection and electrolyte correction 1, 4, 3:
Acute Phase
- Aggressive IV fluid resuscitation with normal saline
- Sodium supplementation (IV initially, then oral sodium chloride)
- Potassium correction (insulin/glucose, calcium gluconate for cardiac protection if severe)
- Sodium bicarbonate for metabolic acidosis
- Antibiotic therapy for documented UTI (culture-directed)
Resolution Timeline
- 76.5% resolve with medical treatment alone 1
- Electrolyte abnormalities typically normalize within days to weeks after UTI treatment
- Surgical correction of underlying uropathy accelerates resolution and prevents recurrence
Surgical Considerations
Early surgical intervention for obstructive uropathy may prevent UTI recurrence and S-PHA episodes 1, 6. In cases requiring immediate surgery (severe obstruction), electrolyte imbalance often resolves post-operatively.
Recurrence Risk
S-PHA can recur with subsequent UTI episodes in infants under 3 months 6, particularly in those with uncorrected obstructive uropathy. This emphasizes the importance of:
- Prophylactic antibiotics until surgical correction
- Close monitoring of electrolytes during any febrile illness
- Expedited surgical correction when feasible
Screening Recommendations
Check serum electrolytes in all infants under 6 months with 1, 3:
- UTI (especially pyelonephritis)
- Known urinary tract malformations presenting for surgery
- Failure to thrive with dehydration
- Any combination of the above
Obtain renal ultrasound in any infant with electrolyte disturbances to exclude obstructive uropathy 7, 3, as this may be the presenting sign of previously undiagnosed CAKUT.
The condition is transient and fully reversible with appropriate treatment, but delayed recognition can result in life-threatening complications including shock, cardiac arrhythmias, and acute kidney injury 4, 5.